“Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma” (2025) Journal of Medical Health Research and Psychiatry, 2(2), pp. 1–9. doi:10.70844/jmhrp.2025.2.2.43.